IP Library Granted Patent US 8,361,484
Granted Patent B2
US 8,361,484 · App. 12/443,021 · Granted Jan 29, 2013

Polymer systems for lung volume reduction therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,361,484
App. No.
12/443,021
Granted
Jan 29, 2013
Kind
B2
Abstract

One aspect of the invention relates to a hydrogel comprising a polymer comprising a plurality of pendent hydroxyl groups, a crosslinker, and a sclerosing agent. Another aspect of the invention relates to a method for reducing lung volume in a patient comprising the steps of advancing into a region of a patient's lung via said patient's trachea a multi-lumen catheter lumen through a bronchoscope; and co-administering, through the multi-lumen catheter, a first mixture comprising a first amount of a polymer containing a plurality of pendent hydroxyl groups; a second mixture comprising a second amount of a crosslinker; and a third mixture comprising a third amount of a sclerosing agent; thereby forming a hydrogel in said region. In certain embodiments, the compositions and methods described herein are intended for use in the treatment of patients with emphysema of the lung.

Claims (18)

1. A method for reducing lung volume in a patient, comprising the steps of:

advancing into a region of a patient's lung via said patient's trachea a multi-lumen catheter lumen through a bronchoscope; and

co-administering, through the multi-lumen catheter, a first mixture comprising a first amount of a polymer containing a plurality of pendent hydroxyl groups; a second mixture comprising a second amount of a crosslinker; and a third mixture comprising a third amount of a sclerosing agent; thereby forming a hydrogel in said region,

wherein said crosslinker is derived from compounds selected from the group consisting of boric acid, sodium borate, potassium borate, alkyl boronic acids, alkyl boronates, alkyl boroxine, alkenyl boronic acids, alkenyl boronates, alkenyl boroxine, aryl boronic acids, aryl boronates, aryl boroxine, heteroaryl boronic acids, heteroaryl boronates, heteroaryl boroxine, aralkyl boronic acid, aralkyl boronates, aralkyl boroxine, heteroaralkyl boronic acids, heteroaralkyl boronates and heteroaralkyl boroxine; and said polymer is polyvinyl alcohol or a copolymer of vinyl alcohol and a second monomer.

2. The method of claim 1 , wherein said polymer is copolymer of vinyl alcohol and a second monomer; wherein said second monomer is selected from the group consisting of olefins, propylene, 1-butene, isobutene, acrylic acid, acrylic acid salts, acrylates, methyl acrylate, ethyl acrylate, n-propyl acrylate, i-propyl acrylate, n-butyl acrylate, i-butyl acrylate, t-butyl acrylate, 2-ethylhexyl acrylate, dodecyl acrylate, octadecyl acrylate, methacrylic acid, methacrylic acid salts, methacrylates, methyl methacrylate, ethyl methacrylate, n-propyl methacrylate, i-propyl methacrylate, n-butyl methacrylate, i-butyl methacrylate, t-butyl methacrylate, 2-ethylhexyl methacrylate, dodecyl methacrylate, octadecyl methacrylate, acrylamide, N-methylacrylamide, N-ethylacrylamide, N,N-dimethylacrylamide, diacetonacrylamide, acrylamidopropanesulfonic acid, salts of acrylamidopropanesulfonic acid, acrylamidopropyldimethylamine, salts of acrylamidopropyldimethylamine, N-methylolacrylamide, methacrylamide, N-methylmethacrylamide, N-ethylmethacrylamide, methacrylamidopropanesulfonic acid, salts of methacrylamidopropanesulfonic acid, methacrylamidopropyldimethylamine, salts of methacrylamidopropyldimethylamine, N-methylolmethacrylamide, N-vinylamides, N-vinylformamide, N-vinylacetamide, N-vinylpyrrolidone, vinyl ethers, methyl vinyl ether, ethyl vinyl ether, n-propyl vinyl ether, i-propyl vinyl ether, n-butyl vinyl ether, i-butyl vinyl ether, t-butyl vinyl ether, dodecyl vinyl ether, stearyl vinyl ether, nitriles, acrylonitrile, methacrylonitrile, vinyl halides, vinyl chloride, vinylidene chloride, vinyl fluoride, vinylidene fluoride, allyl compounds, allyl acetate, allyl chloride, maleic acid, salts of maleic acid, maleic acid esters, itaconic acid, salts of itaconic acid, itaconic acid esters, vinylsilyl compounds, vinyltrimethoxysilane, isopropenyl acetate, N-vinylamides, N-vinylformamide, N-vinylacetamide, and N-vinylpyrrolidone.

3. The method of claim 2 , wherein said copolymer is a block copolymer, random copolymer, graft polymer, or branched copolymer.

4. The method of claim 1 , wherein said crosslinker is derived from an optionally-substituted phenyl boronic acid, an optionally-substituted phenyl boronate, or an optionally-substituted phenyl boroxine.

5. The method of claim 1 , wherein said crosslinker is derived from compounds selected from the group consisting of trans-2-phenylvinylboronic acid, trans-2-(4-chlorophenyl)vinylboronic acid, trans-2-(4-fluorophenyl)vinylboronic acid, trans-2-(4-methoxyphenyl)vinylboronic acid, trans-2-(4-(trifluoromethyl)phenyl)vinylboronic acid, trans-1-hexen-1-ylboronic acid, trans-1-octen-1-ylboronic acid, trans-2-[3-(trifluoromethyl)phenyl]vinylboronic acid, trans-2-(4-biphenyl)vinylboronic acid, trans-2-(3-methoxyphenyl)vinylboronic acid, trans-2-chloromethylvinylboronic acid, (ε)-5-chloro-1-penteneboronic acid, trans-2-(4-methylphenyl)vinylboronic acid, α-phenyl vinylboronic acid, cis-propenylboronic acid, trans-propenylboronic acid, 1-pentenylboronic acid, 2-cyclohexylvinylboronic acid, 1-benzothiophen-2-ylboronic acid, n-boc-2-pyrryl-boronic acid, 2-thienylboronic acid, thiophene-3-boronic acid, 2-furanboronic acid, 2,5-thiophenediboronic acid, 2-formyl-3-thiopheneboronic acid, 3-formyl-2-thiopheneboronic acid, 5-acetyl-2-thiopheneboronic acid, 5-chloro-2-thienylboronic acid, benzofuran-2-ylboronic acid, 4-dibenzofuranboronic acid, benzothiophen-2-ylboronic acid, 4-dibenzothiopheneboronic acid, thianaphthene-3-boronic acid, 3-pyridineboronic acid, 3-furanboronic acid, 5-methyl-2-thiopheneboronic acid, thianthrene-1-boronic acid, 5-methyl-2-furanboronic acid, 5-formyl-2-furanboronic acid, 5-formyl-2-thiopheneboronic acid, 4-methyl-3-thiopheneboronic acid, 5-bromothiophene-2-boronic acid, N-Boc-indole-2-boronic acid, 1-(phenylsulfonyl)-2-indoleboronic acid, 1-(phenylsulfonyl)-3-indoleboronic acid, 4-pyridineboronic acid, 2-chloro-5-pyridineboronic acid, 3-aminophenylboronic acid monohydrate, 3-nitrophenylboronic acid, o-tolylboronic acid, m-tolylboronic acid, p-tolylboronic acid, 3-aminophenylboronic acid hydrochloride, π-phenylenediboronic acid,3-chlorophenylboronic acid, 4-chlorophenylboronic acid, 4-fluorophenylboronic acid, 4-vinylphenylboronic acid, 4-methoxyphenylboronic acid, 2-formylphenylboronic acid, 4-formylphenylboronic acid, 3-(trifluoromethyl)phenylboronic acid, 4-(trifluoromethyl)phenylboronic acid, 3-bromophenylboronic acid, 3-ethoxyphenylboronic acid, 3-fluorophenylboronic acid, 3-formylphenylboronic acid, 3-iodophenylboronic acid, 3-methoxyphenylboronic acid, 2-(trifluoromethyl)phenylboronic acid, 3,5-dichlorophenylboronic acid, 2-chlorophenylboronic acid, 2-fluorophenylboronic acid, 2-methoxyphenylboronic acid, 2-ethoxyphenylboronic acid, 4-ethoxyphenylboronic acid, 3-carboxyphenylboronic acid, 4-carboxyphenylboronic acid, 4,4′-biphenyldiboronic acid, 4-(methylthio)phenylboronic acid, 2,4-difluorophenylboronic acid, 3,4-difluorophenylboronic acid, pentafluorophenylboronic acid, 2,6-difluorophenylboronic acid, 2-acetylphenylboronic acid, 3-acetylphenylboronic acid, 4-acetylphenylboronic acid, 3,5-bis(trifluoromethyl)phenylboronic acid, 3,4-dichlorophenylboronic acid, 3,5-difluorophenylboronic acid, 4-iodophenylboronic acid, 2-bromophenylboronic acid, 4-tert-butylphenylboronic acid, 2,6-dimethylphenylboronic acid, 3,5-dimethylphenylboronic acid, 2,6-dimethoxyphenylboronic acid, 3,4-dimethoxyphenylboronic acid, naphthalene-2-boronic acid, 2-naphthylboronic acid, 4-phenoxyphenylboronic acid, 4-biphenylboronic acid, 2,4-dimethoxyphenylboronic acid, 2,5-dimethoxyphenylboronic acid, 2,3-dimethylphenylboronic acid, 2,5-dimethylphenylboronic acid, 4-(dimethylamino)phenylboronic acid, 5-fluoro-2-methoxyphenylboronic acid, 4-fluoro-3-methylphenylboronic acid, 3,5-dibromophenylboronic acid, 4-ethylphenylboronic acid, 3,4-(methylenedioxy)phenylboronic acid, 3-(trifluoromethoxy)phenylboronic acid, 4-(trifluoromethoxy)phenylboronic acid, 2-fluoro-4-biphenylylboronic acid, 3-chloro-4-fluorophenylboronic acid, 5-chloro-2-methoxyphenylboronic acid, 5-formyl-2-methoxyphenylboronic acid, 2,3,4-trimethoxyphenylboronic acid, 2,5-dichlorophenylboronic acid, 4-(hydroxymethyl)phenylboronic acid, 4-borono-dl-phenylalanine, 5-bromo-2-methoxyphenylboronic acid, 2-chloro-6-methoxyphenylboronic acid, 2-fluoro-6-methoxyphenylboronic acid, 5-bromo-2-ethoxyphenylboronic acid, 3-(hydroxymethyl)phenylboronic acid, 3-formyl-4-methoxyphenylboronic acid, 3-cyanophenylboronic acid, 2,5-difluorophenylboronic acid, 2,3-difluorophenylboronic acid, 2,3-dichlorophenylboronic acid, 2-(methylthio)phenylboronic acid, 2-benzyloxyphenylboronic acid, 2,4-dichlorophenylboronic acid, 2-cyanophenylboronic acid, 4-cyanophenylboronic acid, 4-methyl-1-naphthaleneboronic acid, 4-methyl-3-nitrophenylboronic acid, 2-phenoxyphenylboronic acid, 4-butylphenylboronic acid, 4-propylphenylboronic acid, 2-ethylphenylboronic acid, 2-ethoxy-1-naphthaleneboronic acid, 6-methoxy-2-naphthaleneboronic acid, 6-ethoxy-2-naphthaleneboronic acid, 3-(trimethylsilyl)phenylboronic acid, 4-(trimethylsilyl)phenylboronic acid, 3-hydroxyphenylboronic acid, 4-hydroxyphenylboronic acid, 3-mercaptophenylboronic acid, 4-mercaptophenylboronic acid, 3-(tert-butyldimethylsilyoxy)phenylboronic acid, 2,3,4-trifluorophenylboronic acid, 2,3,6-trifluorophenylboronic acid, 2,4,6-trifluorophenylboronic acid, 2,4,5-trifluorophenylboronic acid, 2,3,5-trifluorophenylboronic acid, 3,4,5-trifluorophenylboronic acid, 4-benzoylphenylboronic acid, 3-benzyloxyphenylboronic acid, 3-biphenylboronic acid, 2-biphenylboronic acid, 3-fluoro-4-formylphenylboronic acid, 2,4,6-trimethylphenylboronic acid, 2,4,5-trimethylphenylboronic acid, 3-isopropoxyphenylboronic acid, 2-isopropoxyphenylboronic acid, 4-isopropoxyphenylboronic acid, 2-butoxyphenylboronic acid, 3-butoxyphenylboronic acid, 4-butoxyphenylboronic acid, 3-bromo-2-ethoxy-5-fluorophenylboronic acid, 5-chloro-2-ethoxyphenylboronic acid, 1-pyreneboronic acid, 4-bromo-2,6-difluorophenylboronic acid, 3-chloro-2-fluorophenylboronic acid, 5-chloro-2-fluorophenylboronic acid, 3-bromo-2,6-difluorophenylboronic acid, 2-chloro-6-fluoro-3-methylphenylboronic acid, 2-chloro-6-fluoro-5-methylphenylboronic acid, 5-chloro-2-fluoro-3-methylphenylboronic acid, 4-propoxyphenylboronic acid, 3-propoxyphenylboronic acid, 2-propoxyphenylboronic acid, 2,3-dimethoxyphenylboronic acid, 2-fluoro-5-(trifluoromethyl)phenylboronic acid, 3-bromo-2-fluorophenylboronic acid, 3-fluoro-4-methoxyphenylboronic acid, 4-ethoxy-3-fluorophenylboronic acid, 3-fluoro-4-isopropoxyphenylboronic acid, 4-butoxy-3-chlorophenylboronic acid, 3-chloro-4-isopropoxyphenylboronic acid, 3-chloro-4-propoxyphenylboronic acid, 3-chloro-4-ethoxyphenylboronic acid, 3-chloro-4-methoxyphenylboronic acid, 2-butoxy-5-fluorophenylboronic acid, 5-fluoro-2-isopropoxyphenylboronic acid, 5-methyl-2-propoxyphenylboronic acid, 4-fluoro-2-methylphenylboronic acid, 2-isopropoxy-5-methylphenylboronic acid, 2-butoxy-5-methylphenylboronic acid, 5-fluoro-2-propoxyphenylboronic acid, 4-acetamidophenylboronic acid, 4-(n-boc-amino)phenylboronic acid, 3-acetamidophenylboronic acid, 2-chloro-6-fluorophenylboronic acid, 9,9-dihexylfluorene-2,7-dioronic acid, 2-fluoro-4-methylphenylboronic acid, 3-fluoro-4-methylphenylboronic acid, 2-fluoro-5-methylphenylboronic acid, acenaphthene-5-boronic acid, 3,5-diformylphenylboronic acid, 2-ethoxy-5-methylphenylboronic acid, 2-methoxy-5-methylphenylboronic acid, 9,9-dioctylfluorene-2,7-diboronic acid, 2,3-difluoro-4-formylphenylboronic acid, 9,9-didodecylfluorene-2,7-diboronic acid, 9,9-di(2′-ethylhexyl)fluorene-2,7-diboronic acid, 4-ethoxycarbonylphenylboronic acid, 3-ethoxycarbonylphenylboronic acid, n-(4-phenylboronic)succinamic acid, 3-methoxycarbonylphenylboronic acid, 3-bromo-2-butoxyphenylboronic acid, 2,6-difluoro-4-methoxyphenylboronic acid, 2-fluoro-5-iodophenylboronic acid, 2-fluoro-3-iodophenylboronic acid, 5-bromo-2-fluorophenylboronic acid, 2-bromo-6-fluorophenylboronic acid, 4-bromo-2,3,5,6-tetrafluorophenylboronic acid, 2-fluoro-3-methoxyphenylboronic acid, 2-fluoro-3-methoxyphenylboronic acid, 2-fluoro-5-propoxyphenylboronic acid, 5-ethoxy-2-fluorophenylboronic acid, 2-ethoxy-6-fluorophenylboronic acid, 4-methoxycarbonylpheynlboronic acid, 4-butoxy-2-methylphenylboronic acid, 4-ethoxy-2-methylphenylboronic acid, 2-ethoxy-5-fluorophenylboronic acid, 4-methoxy-3-methylphenylboronic acid, 4-benzyloxy-3-chlorophenylboronic acid, 3-bromo-5-methyl-2-methoxyphenylboronic acid, 3-bromo-2-ethoxy-5-methylphenylboronic acid, 3-bromo-2-isopropoxy- 5 -methylphenylboronic acid, 3-bromo-5-methyl-2-propoxyphenylboronic acid, 3-bromo-2-butoxy-5-methylphenylboronic acid, 3-bromo-2-propoxyphenylboronic acid, 2-fluoro-5-methoxyphenylboronic acid, 3-bromo-2-isopropoxyphenylboronic acid, 3-(ethylthio)phenylboronic acid, 2,4-difluoro-3-formylphenylboronic acid, 4-butoxy-3,5-dimethylphenylboronic acid, 3,5-dimethyl-4-propoxyphenylboronic acid, 3,5-dimethyl-4-ethoxyphenylboronic acid, 3,5-dimethyl-4-methoxyphenylboronic acid, 3-benzyloxy-2,6-difluorophenylboronic acid, 3-(2′-chlorobenzyloxy)phenylboronic acid, 4-(3′,5′-dimethoxybenzyloxy)phenylboronic acid, 3-(3′,5′-dimethoxybenzyloxy)phenylboronic acid, 2-bromo-5,6-difluorophenylboronic acid, 2-fluoro-6-propoxyphenylboronic acid, 2-benzyloxy-3-bromo-5-methylphenylboronic acid, 2-(2′-chlorobenzyloxy)phenylboronic acid, 3-aminophenylboronic acid, 4-bromophenylboronic acid, 1-naphthylboronic acid, phenylboronic acid, butylboronic acid, methylboronic acid, (2-methylpropyl)boronic acid, and the corresponding boronates and boroxines thereof.

6. The method of claim 1 , wherein said sclerosing agent comprises a polycation; said polycation is a poly(amino acid); and said poly(amino acid) comprises a plurality of amino acids independently selected from the group consisting of Lys and Arg; and a plurality of amino acids independently selected from the group consisting of Gly, Ala, Val, Leu, Ile, Met, Pro, Phe, Trp, Asn, Gln, Ser, Thr, Tyr, Cys, and His; provided that no less than twenty-five percent of the amino acids is independently selected from the group consisting of Lys and Arg; further provided that no more than five percent of the amino acids is independently selected from the group consisting of Asp and Glu.

7. The method of claim 1 , wherein said sclerosing agent comprises a polycation; said polycation is a poly(amino acid); said poly(amino acid) is represented by poly(X-Y), poly(X-Y-Y), or poly(X-Y-Y-Y); X is independently for each occurrence Lys or Arg; and Y is independently for each occurrence Gly, Ala, Val, Leu, Ile, Met, Pro, Phe, Trp, Asn, Gln, Ser, Thr, Tyr, Cys, or His.

8. The method of claim 1 , wherein the third mixture further comprises a fourth amount of a polyanion; and the sclerosing agent comprises a polycation.

9. The method of claim 1 , wherein said sclerosing agent is a peroxide.

10. The method of claim 9 , wherein said peroxide is hydrogen peroxide, a peroxyborate, a peroxyboric acid, a peroxycarbonate, a peroxycarbonic acid, an alkyl hydroperoxide, an aryl hydroperoxide, an aralkyl hydroperoxide, a peroxyacetate, or a peroxyacetic acid.

11. The method of claim 9 , wherein said peroxide is sodium perborate, sodium percarbonate, or sodium peracetate.

12. The method of claim 1 , further comprising the step of co-administering to said patient a contrast-enhancing agent.

13. The method of claim 12 , wherein said contrast-enhancing agent is selected from the group consisting of radiopaque materials, paramagnetic materials, heavy atoms, transition metals, lanthanides, actinides, dyes, and radionuclide-containing materials.

14. The method of claim 1 , wherein the sclerosing agent is polylysine.

15. The method of claim 1 , wherein the sclerosing agent is poly(l-lysine).

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0822 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2019
From: AERIS THERAPEUTICS, LLC.
To: PULMONX
Reel/Frame 048682/0506 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
RELEASE OF SECURITY INTEREST Recorded May 26, 2015
From: ROSSE ENTERPRISES, LTD.
To: AERIS THERAPEUTICS, LLC.
Reel/Frame 035714/0886 →
SECURITY AGREEMENT Recorded Feb 9, 2012
From: AERIS THERAPEUTICS, LLC
To: ROSSE ENTERPRISES, LTD.
Reel/Frame 027683/0003 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2011
From: AERIS THERAPEUTICS, INC.
To: AERIS THERAPEUTICS, LLC
Reel/Frame 026170/0254 →